Other Growth products — Total Revenues
Bristol-Myers Squibb Other Growth products — Total Revenues increased by 9.4% to $514.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.7%, from $433.00M to $514.00M. Over 2 years (FY 2022 to FY 2024), Other Growth products — Total Revenues shows an upward trend with a 21.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market penetration and adoption of the company's newer therapeutic offerings, while a decrease may signal competitive pressure or slower-than-expected uptake of the growth portfolio.
Detailed definition
This metric represents the aggregate revenue generated from a specific portfolio of pharmaceutical products identified b...
Peer comparison
Peers in the biopharmaceutical industry typically report similar metrics under 'New Product Revenue' or 'Growth Portfolio Sales' to demonstrate the sustainability of their revenue pipeline.
bmy_segment_other_growth_products_total_revenuesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $273.00M | $273.00M | $273.00M | $273.00M | $280.00M | $295.00M | $311.00M | $325.00M | $319.00M | $341.00M | $433.00M | $512.00M | $403.00M | $470.00M | $514.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.6% | +5.4% | +5.4% | +4.5% | -1.8% | +6.9% | +27.0% | +18.2% | -21.3% | +16.6% | +9.4% |
| YoY Change | — | — | — | — | +2.6% | +8.1% | +13.9% | +19.0% | +13.9% | +15.6% | +39.2% | +57.5% | +26.3% | +37.8% | +18.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's other growth products — total revenues?
- Bristol-Myers Squibb (BMY) reported other growth products — total revenues of $514.00M in Q3 2025.
- How has Bristol-Myers Squibb's other growth products — total revenues changed year-over-year?
- Bristol-Myers Squibb's other growth products — total revenues increased by 18.7% year-over-year, from $433.00M to $514.00M.
- What is the long-term trend for Bristol-Myers Squibb's other growth products — total revenues?
- Over 2 years (2022 to 2024), Bristol-Myers Squibb's other growth products — total revenues has grown at a 21.2% compound annual growth rate (CAGR), from $1.09B to $1.61B.
- What does other growth products — total revenues mean?
- Total sales revenue from a designated group of newer or high-potential pharmaceutical products intended to drive future growth.